VYREX CORPORATION, based in La Jolla, California, is a biopharmaceutical discovery and development company. Vyrex is engaged in research, discovery and development of innovative small molecule pharmaceutical, nutraceutical and cosmeceutical products for treatment and prevention of various diseases and disorders associated with human aging.
Sheldon S. Hendler, Ph.D., M.D., the Company's Chairman, Founder, and Director of Scientific and Medical Affairs, has broad experience in multiple scientific and medical disciplines, including biochemistry, molecular biology, genetics, virology, medicinal chemistry, basic research, clinical research, internal medicine and dermatology. He is published in the world's leading scientific and medical journals, including The New England Journal of Medicine, Nature and Proceedings of the National Academy of Sciences and is a named inventor on numerous patents, including those relating to the Company's technologies.
Dr. Hendler has also written several award-winning popular books, including The Doctors' Vitamin and Mineral Encyclopedia (Simon & Schuster) and the Physicians' Desk Reference (PDR) for Nutritional Supplements. The PDR® for Nutritional Supplements comprehensively evaluates all of the various nutritional supplements used throughout the world. It is "considered the standard reference book in the field" (New York Times, March 9,2004).
Dr. Hendler is a Clinical Professor of Medicine (Voluntary), University of California, San Diego and an Attending Physician at Scripps Mercy Hospital in San Diego. He received his Ph.D. in biochemistry from Columbia University and his M.D. from the University of California, San Diego and is a Fellow of the American Institute of Chemists and the American College of Nutrition. Dr. Hendler is also Co-Editor-in-Chief of the international, peer-reviewed Journal of Medicinal Food (Mary Ann Liebert, Publishers).
G. Dale Garlow became Vyrex's Chief Executive Officer and President in 2000. He succeeded Dr. Sheldon Hendler, becoming the second CEO and President in Vyrex's history. In 2000, he was also appointed a member of the Vyrex Board of Directors. Mr. Garlow has extensive and diversified managerial skills in the pharmaceutical, biotech and nutraceutical industries.
Mr. Garlow's prior key executive positions include: Partner in Integra LLC, a Company involved in operations, sales and marketing of pharmaceuticals, over-the-counter products, vitamins and medical diagnostics; President, CEO and Co-Founder of FHC Corporation, a Company that developed and obtained exclusive world wide marketing rights for a home pregnancy test which was sold in an exclusive supply agreement to Warner Lambert for marketing as their brand ept®; President and CEO of Whiteworth/Towne Paulsen a manufacturer and distributor of health and beauty aids and generic prescription pharmaceuticals, and Regional Director of Administration and Distribution for the Upjohn Pharmaceutical Company. Garlow has served on the boards of a number of companies, including DNA Technologies and Nucleic Assays. He majored in business administration and marketing at the University of Missouri.
Michael L. Eagle recently retired as the Vice President of Manufacturing for Eli Lilly and Company. He was with Eli Lilly for 18 years beginning as the Vice President of Manufacturing for Advanced Cardiovascular Systems, now a part of Guidant Corporation. Mr. Eagle currently sits on the Boards of several medical device and equipment manufacturers and is a founding member of Barnard Life Sciences, LLC, a firm focusing on life science businesses.
Mr. Eagle's prior key executive positions include; Senior Vice President of Operations for Advanced Cardiovascular Systems, President and CEO of IVAC Corporation (another Eli Lilly subsidiary) and Vice President of the Medical Device and Diagnostics Division of Eli Lilly with responsibility for all vascular, surgical and medical device businesses, including those businesses located in Japan.
Michael L. Eagle is a member of the Board of Directors.
Richard McKee, Jr. is Managing General Partner of Dynamic Value Partners, Ltd., a Florida investment partnership specializing in small-cap stocks. Previously he served as a director and portfolio manager at Fundamental Management Corporation in Miami, Florida and as Vice President of First Equity Corporation of Florida, a regional investment-banking firm. Mr. Mckee is a graduate of Brown University.
Richard McKee, Jr. is a member of the Board of Directors.
Tom K. Larson, Jr. is President and CEO of Accelerated Capital Funding, a start up company involved in raising capital for housing for Native Americans, Handicapped and Elderly Individuals. Prior to joining Vyrex, Mr Larson served as Vice President, Finance and Administration and CFO of INAMED Corporation, a global surgical and medical device company.
Mr. Larson's previous positions include Vice President, Finance and CFO of a privately held specialty bed manufacturer, Vice President, Finance and CFO Revell Corporation, and held a number of key executive financial and administrative positions at Xerox Corporation. In addition he was an Equity Owner and Operation Officer of four separate corporations and is experienced in turnaround situations.
Tom K. Larson, Jr. is a member of the Board of Directors.
Vyrex Corporation is a La Jolla, California based Biopharmaceutical Company seeking to discover and develop pharmaceutical, nutraceutical and cosmeceutical products for the treatment and prevention of respiratory, cardiovascular and neurodegenerative diseases and conditions associated with aging. To date the Company has focused on developing targeted anti-oxidant therapeutics for respiratory, neurological and cardiovascular diseases and the development of nutraceuticals and cosmeceuticals for the support of certain age related conditions.
